CClinicalTrials.gg
CompletedNCT02212314WSRITUpdated May 31, 2017

Response Inhibition Training for Children With Williams Syndrome

An interventional study of Response Inhibition Training in Williams Syndrome, sponsored by University of Wisconsin, Milwaukee. Completed at 1 site in United States. Open to participants aged 10 Years to 17 Years. Per ClinicalTrials.gov, last updated 2017-05-31.

Sponsored by University of Wisconsin, Milwaukee · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
10 Years to 17 Years
Sex
All
01

Study summary

The investigators will conduct a pilot study investigating the effectiveness of a computerized response inhibition training program at reducing the response inhibition difficulties often seen in children with Williams syndrome ages 10-17. The investigators hypothesize that after completing the training program, children with Williams syndrome will show improvement on computerized measures of response inhibition and on parent measures of impulsivity.

Read the detailed description

Behavioral characteristics of individuals with Williams syndrome include eagerness to approach and interact with others (including strangers), repeated questions especially about upcoming events, and difficulties with attention, impulsivity, and inhibition. There is very little systematic research about the kinds of interventions that are most useful for children with Williams syndrome to support optimal psychosocial functioning, and of the effectiveness of such interventions. We will conduct a pilot study of a potential intervention to address the response inhibition difficulties associated with Williams syndrome. The investigators will examine the utility of an online, web-based computerized cognitive retraining program aimed at addressing impulsivity and inhibition difficulties in 20 children, ages 10-17, with WS. The engaging training program has shown some utility in other populations, including children with tic disorders and trichotillomania. The investigators will examine the acceptability and feasibility of the treatment approach, as well as its impact on performance on experimental measures of impulsivity and on everyday psychosocial functioning as rated by parents; this study will consist of a small-scale pilot Randomized Clinical Trial with wait list. Through this novel work, we hope to develop and tune this approach for optimal outcomes and to demonstrate the promise of this intervention to address common challenges of people with Williams syndrome in the area of inhibition.

02

Conditions studied

  • Williams Syndrome

Keywords

  • Response Inhibition, Williams Syndrome
03

In context

Williams Syndrome

29 studies on the registry are indexed under Williams Syndrome; 11 are open to participants now.

This study's enrollment of 25 is below the median of 60 across 12 interventional studies indexed under Williams Syndrome.

Browse Williams Syndrome studies →

Lead sponsor

University of Wisconsin, Milwaukee is the lead sponsor of 33 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Williams syndrome (diagnosed with genetic testing)
  • Ages 10-17
  • First language and main language spoken in the home is English
  • Possess computer in the home that has internet access, and a second electronic device with access to Skype (e.g., smartphone, ipad, additional computer, ipod touch)

Exclusion criteria

Exclusion Criteria:

  • First language and main language spoken in the home is NOT English (because study measures and instructions are all in English)
  • No computer in the home with internet access (because the study is being conducted via the internet)
  • Comorbid severe illnesses or major surgery within the past 6 months
  • Four or more previous sessions of inhibition training
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
25 participants (actual)

Study arms

  • Experimental
    Response Inhibition Training

    Treatment group will receive immediate treatment after pre-test.

    Behavioral: Response Inhibition Training

  • No intervention
    Waitlist Crossover

    Waitlist group will not receive intervention while treatment group is active, but waitlist group will be offered treatment after post-test is completed.

Interventions

  • BehavioralResponse Inhibition Training

    Computerized response inhibition training will be delivered via the Internet for 10 individual sessions.

06

What researchers measure

Primary outcomes

  1. Cognitive Inhibition Tasks

    Three measures of response inhibition that were administered to children at pre-test will be administered after the 5-7-week training and again at a 3-month follow-up. Measures include computer-administered Motor Stroop task, Stop Signal task, and Go/No-Go Task.

    Time frame: 5-7 weeks and 3 months

Secondary outcomes

  1. Conners-3

    The Conners-3 will be administered to parents at post-intervention and again at follow-up to assess changes in attention and impulsivity.

    Time frame: 5-7 weeks and 3 months

  2. Emotion Regulation Checklist

    The Emotion Regulation Checklist will be administered to parents at post-intervention and follow-up to assess changes in the child's ability to regulate emotions.

    Time frame: 5-7 weeks and 3 months

  3. Positive and Negative Affect Scale

    The PANAS will be administered to parents at post-intervention and follow-up to assess changes in child positive and negative affect.

    Time frame: 5-7 weeks and 3 months

  4. Question-Asking Questionnaire

    The QAQ will be administered to parents at post-intervention and follow-up to assess changes in amount and frequency of child anticipatory question asking.

    Time frame: 5-7 weeks and 3 months

  5. Spence Children's Anxiety Scale

    The SCAS will be administered to parents at post-intervention and follow-up to assess changes in child anxieties.

    Time frame: 5-7 weeks, 3 months

  6. MINI Kid 6.0 Parent Version

    The MINI Kid 6.0 Parent will be administered to parents at post-intervention and follow-up to assess changes in those areas endorsed at pre-intervention.

    Time frame: 5-7 weeks and 3 months

Other outcomes

  1. Treatment Acceptability Questionnaire

    Questionnaire about study acceptability will be administered at post test after the 5-7 week training.

    Time frame: 5-7 weeks

  2. Treatment Evaluation Inventory

    Questionnaire evaluating treatment will be administered at post test after the 5-7 week training.

    Time frame: 5-7 weeks

07

Study locations

1 site
  • University of Wisconsin-Milwaukee Child Neurodevelopment Research Lab
    Milwaukee, Wisconsin 53211, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 31, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02212314
Lead sponsor
University of Wisconsin, Milwaukee
Responsible party
Bonita P Klein-Tasman (Professor, University of Wisconsin, Milwaukee) — Principal investigator
First posted
Aug 8, 2014
Start date
May 2014
Primary completion
May 2016
Completion
May 2016
Last update
May 31, 2017

Study contacts

Bonita P Klein-Tasman, Ph.D.
principal investigator · University of Wisconsin, Milwaukee

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion